241 related articles for article (PubMed ID: 32381549)
21. Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression.
Sadatsuki R; Kaneko H; Kinoshita M; Futami I; Nonaka R; Culley KL; Otero M; Hada S; Goldring MB; Yamada Y; Kaneko K; Arikawa-Hirasawa E; Ishijima M
J Orthop Res; 2017 Apr; 35(4):837-846. PubMed ID: 27238423
[TBL] [Abstract][Full Text] [Related]
22. A mouse model of Schwartz-Jampel syndrome reveals myelinating Schwann cell dysfunction with persistent axonal depolarization in vitro and distal peripheral nerve hyperexcitability when perlecan is lacking.
Bangratz M; Sarrazin N; Devaux J; Zambroni D; Echaniz-Laguna A; René F; Boërio D; Davoine CS; Fontaine B; Feltri ML; Benoit E; Nicole S
Am J Pathol; 2012 May; 180(5):2040-55. PubMed ID: 22449950
[TBL] [Abstract][Full Text] [Related]
23. Perlecan in late stages of osteoarthritis of the human knee joint.
Tesche F; Miosge N
Osteoarthritis Cartilage; 2004 Nov; 12(11):852-62. PubMed ID: 15501400
[TBL] [Abstract][Full Text] [Related]
24. Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes.
Johnson BB; Cosson MV; Tsansizi LI; Holmes TL; Gilmore T; Hampton K; Song OR; Vo NTN; Nasir A; Chabronova A; Denning C; Peffers MJ; Merry CLR; Whitelock J; Troeberg L; Rushworth SA; Bernardo AS; Smith JGW
Cell Rep; 2024 Jan; 43(1):113668. PubMed ID: 38198277
[TBL] [Abstract][Full Text] [Related]
25. Role of perlecan in skeletal development and diseases.
Hassell J; Yamada Y; Arikawa-Hirasawa E
Glycoconj J; 2002; 19(4-5):263-7. PubMed ID: 12975604
[TBL] [Abstract][Full Text] [Related]
26. Perlecan/HSPG2: Signaling role of domain IV in chondrocyte clustering with implications for Schwartz-Jampel Syndrome.
Martinez JR; Grindel BJ; Hubka KM; Dodge GR; Farach-Carson MC
J Cell Biochem; 2019 Feb; 120(2):2138-2150. PubMed ID: 30203597
[TBL] [Abstract][Full Text] [Related]
27. Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues.
Melrose J; Hayes AJ; Whitelock JM; Little CB
Bioessays; 2008 May; 30(5):457-69. PubMed ID: 18404701
[TBL] [Abstract][Full Text] [Related]
28. Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development.
Arikawa-Hirasawa E; Wilcox WR; Yamada Y
Am J Med Genet; 2001; 106(4):254-7. PubMed ID: 11891676
[TBL] [Abstract][Full Text] [Related]
29. Chondrocyte Intracellular Matrix Strain Fields of Articular Cartilage Surface in Hyperglycemia Model of Rat: Cellular Morphological Study.
Njoto I; Soekanto A; Ernawati E; Abdurrachman A; Kalim H; Handono K; Soeatmadji DW; Fatchiyah F
Med Arch; 2018 Nov; 72(5):348-351. PubMed ID: 30524167
[TBL] [Abstract][Full Text] [Related]
30. Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia.
Vranka J; Mokashi A; Keene DR; Tufa S; Corson G; Sussman M; Horton WA; Maddox K; Sakai L; Bächinger HP
Matrix Biol; 2001 Nov; 20(7):439-50. PubMed ID: 11691584
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive profiling of cartilage extracellular matrix formation and maturation using sequential extraction and label-free quantitative proteomics.
Wilson R; Diseberg AF; Gordon L; Zivkovic S; Tatarczuch L; Mackie EJ; Gorman JJ; Bateman JF
Mol Cell Proteomics; 2010 Jun; 9(6):1296-313. PubMed ID: 20190199
[TBL] [Abstract][Full Text] [Related]
32. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.
Thompson WR; Modla S; Grindel BJ; Czymmek KJ; Kirn-Safran CB; Wang L; Duncan RL; Farach-Carson MC
J Bone Miner Res; 2011 Mar; 26(3):618-29. PubMed ID: 20814969
[TBL] [Abstract][Full Text] [Related]
33. Role of collagen type II and perlecan in skeletal development.
Gustafsson E; Aszodi A; Ortega N; Hunziker EB; Denker HW; Werb Z; Fassler R
Ann N Y Acad Sci; 2003 May; 995():140-50. PubMed ID: 12814946
[TBL] [Abstract][Full Text] [Related]
34. Perlecan/Hspg2 deficiency impairs bone's calcium signaling and associated transcriptome in response to mechanical loading.
Pei S; Parthasarathy S; Parajuli A; Martinez J; Lv M; Jiang S; Wu D; Wei S; Lu XL; Farach-Carson MC; Kirn-Safran CB; Wang L
Bone; 2020 Feb; 131():115078. PubMed ID: 31715337
[TBL] [Abstract][Full Text] [Related]
35. FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer.
Vincent TL; McLean CJ; Full LE; Peston D; Saklatvala J
Osteoarthritis Cartilage; 2007 Jul; 15(7):752-63. PubMed ID: 17368052
[TBL] [Abstract][Full Text] [Related]
36. Confocal microscopy demonstrates association of LTBP-2 in fibrillin-1 microfibrils and colocalisation with perlecan in the disc cell pericellular matrix.
Hayes AJ; Gibson MA; Shu C; Melrose J
Tissue Cell; 2014 Jun; 46(3):185-97. PubMed ID: 24867584
[TBL] [Abstract][Full Text] [Related]
37. Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton.
Parajuli A; Pei S; Zhao H; Martinez JR; Lu XL; Liu XS; Farach-Carson MC; Kirn-Safran CB; Wang L
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32013135
[TBL] [Abstract][Full Text] [Related]
38. A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice.
Jacenko O; Chan D; Franklin A; Ito S; Underhill CB; Bateman JF; Campbell MR
Am J Pathol; 2001 Dec; 159(6):2257-69. PubMed ID: 11733375
[TBL] [Abstract][Full Text] [Related]
39. Focus on molecules: perlecan (HSPG2).
Smith S; Hassell JR
Exp Eye Res; 2006 Sep; 83(3):471-2. PubMed ID: 16549064
[No Abstract] [Full Text] [Related]
40. Electrophysiological studies in a mouse model of Schwartz-Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin.
Echaniz-Laguna A; Rene F; Marcel C; Bangratz M; Fontaine B; Loeffler JP; Nicole S
Muscle Nerve; 2009 Jul; 40(1):55-61. PubMed ID: 19367640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
